As of May 27
| -0.0287 / -6.69%|
The 1 analysts offering 12-month price forecasts for Cyclacel Pharmaceuticals Inc have a median target of 5.00, with a high estimate of 5.00 and a low estimate of 5.00. The median estimate represents a +1,150.00% increase from the last price of 0.40.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.